Lenalidomide (LEN) pharmacokinetics (PKs) in multiple myeloma (MM) patients (pts) with various renal functions.

8039Background: LEN is a backbone drug used in the treatment of MM. Because over 80% LEN is excreted unchanged in urine, dose modifications for RD are recommended, based on PK evaluation following ...